PRECISION ONCOLOGY SITE NETWORK Trademark

Trademark Overview

On Wednesday, July 31, 2019, a trademark application was filed for PRECISION ONCOLOGY SITE NETWORK with the United States Patent and Trademark Office. The USPTO has given the PRECISION ONCOLOGY SITE NETWORK trademark a serial number of 88555117. The federal status of this trademark filing is REGISTERED as of Tuesday, July 6, 2021. This trademark is owned by Precision Medicine Group, LLC. The PRECISION ONCOLOGY SITE NETWORK trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting personalized clinical trials
precision oncology site network

General Information

Serial Number88555117
Word MarkPRECISION ONCOLOGY SITE NETWORK
Filing DateWednesday, July 31, 2019
Status700 - REGISTERED
Status DateTuesday, July 6, 2021
Registration Number6411991
Registration DateTuesday, July 6, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2020

Trademark Statements

NOT AVAILABLE"ONCOLOGY SITE NETWORK"
Goods and ServicesMedical and scientific research, namely, conducting personalized clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 12, 2020
Primary Code042
First Use Anywhere DateThursday, May 21, 2020
First Use In Commerce DateThursday, May 21, 2020

Trademark Owner History

Party NamePrecision Medicine Group, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBethesda, MD 20814
US
Party NamePrecision Medicine Group, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBethesda, MD 20814
US
Party NamePrecision Medicine Group, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBethesda, MD 20814
US

Trademark Events

Event DateEvent Description
Saturday, August 3, 2019NEW APPLICATION ENTERED
Thursday, August 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 26, 2019ASSIGNED TO EXAMINER
Monday, November 4, 2019NON-FINAL ACTION WRITTEN
Monday, November 4, 2019NON-FINAL ACTION E-MAILED
Monday, November 4, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 7, 2020ASSIGNED TO LIE
Tuesday, May 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 3, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 23, 2020PUBLISHED FOR OPPOSITION
Tuesday, June 23, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 4, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 4, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 4, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, January 4, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 18, 2021TEAS STATEMENT OF USE RECEIVED
Monday, March 8, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 18, 2021USE AMENDMENT FILED
Monday, March 8, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 6, 2021SU - NON-FINAL ACTION - WRITTEN
Tuesday, April 6, 2021NON-FINAL ACTION E-MAILED
Tuesday, April 6, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 4, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 6, 2021ASSIGNED TO LIE
Thursday, May 6, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 6, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 1, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 2, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 6, 2021REGISTERED-PRINCIPAL REGISTER
Monday, July 6, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

network site oncology precision personalized clinical trials conducting namely scientific research medical